BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen K, Zeng J, Tang K, Xiao H, Hu J, Huang C, Yao W, Yu G, Xiao W, Guan W, Guo X, Xu H, Ye Z. miR-490-5p suppresses tumour growth in renal cell carcinoma through targeting PIK3CA. Biol Cell. 2016;108:41-50. [PMID: 26559013 DOI: 10.1111/boc.201500033] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang G, Jiang Y, Lu C, Jiang W, Wu S, Hua Y. CircFOXM1 promotes proliferation and metastasis of hepatocellular carcinoma via regulating miR-1179/SPAG5 axis. Sci Rep 2021;11:23890. [PMID: 34903799 DOI: 10.1038/s41598-021-03285-w] [Reference Citation Analysis]
2 Wang J, Zhang X, Yao H, Le Y, Zhou W, Li J, Lu L, Chen M, Li X. MiR-490-5p functions as tumor suppressor in childhood neuroblastoma by targeting MYEOV. Human Cell 2020;33:261-71. [DOI: 10.1007/s13577-019-00302-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
3 Zhang H, Bao J, Zhao S, Huo Z, Li B. MicroRNA-490-3p suppresses hepatocellular carcinoma cell proliferation and migration by targeting the aurora kinase A gene (AURKA). Arch Med Sci 2020;16:395-406. [PMID: 32190151 DOI: 10.5114/aoms.2019.91351] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
4 Ren H, Mai G, Liu Y, Xiang R, Yang C, Su W. Eukaryotic Translation Initiation Factor 3 Subunit B Is a Promoter in the Development and Progression of Pancreatic Cancer. Front Oncol 2021;11:644156. [PMID: 33996561 DOI: 10.3389/fonc.2021.644156] [Reference Citation Analysis]
5 Li Y, Tian D, Chen H, Cai Y, Chen S, Duan S. MicroRNA-490-3p and -490-5p in carcinogenesis: Separate or the same goal? Oncol Lett 2021;22:678. [PMID: 34345303 DOI: 10.3892/ol.2021.12939] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Herdoiza Padilla E, Crauwels P, Bergner T, Wiederspohn N, Förstner S, Rinas R, Ruf A, Kleemann M, Handrick R, Tuckermann J, Otte K, Walther P, Riedel CU. mir-124-5p Regulates Phagocytosis of Human Macrophages by Targeting the Actin Cytoskeleton via the ARP2/3 Complex. Front Immunol 2019;10:2210. [PMID: 31636629 DOI: 10.3389/fimmu.2019.02210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Li J, Xu X, Liu C, Xi X, Wang Y, Wu X, Li H. MiR-490-5p Restrains Progression of Gastric cancer through DTL Repression. Gastroenterol Res Pract 2021;2021:2894117. [PMID: 34594374 DOI: 10.1155/2021/2894117] [Reference Citation Analysis]
8 Fang ZQ, Li MC, Zhang YQ, Liu XG. MiR-490-5p inhibits the metastasis of hepatocellular carcinoma by down-regulating E2F2 and ECT2. J Cell Biochem 2018;119:8317-24. [PMID: 29932246 DOI: 10.1002/jcb.26876] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
9 Vinchure OS, Kulshreshtha R. miR-490: A potential biomarker and therapeutic target in cancer and other diseases. J Cell Physiol 2021;236:3178-93. [PMID: 33094503 DOI: 10.1002/jcp.30119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jiang J, Han P, Qian J, Zhang S, Wang S, Cao Q, Shao P. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma. Exp Cell Res 2020;392:112029. [PMID: 32330508 DOI: 10.1016/j.yexcr.2020.112029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Chen W, Ye L, Wen D, Chen F. MiR-490-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion by Directly Regulating ROBO1. Pathol Oncol Res 2019;25:1-9. [PMID: 28924964 DOI: 10.1007/s12253-017-0305-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
12 Wei H, Yan S, Hui Y, Liu Y, Guo H, Li Q, Li J, Chang Z. CircFAT1 promotes hepatocellular carcinoma progression via miR-30a-5p/REEP3 pathway. J Cell Mol Med 2020;24:14561-70. [PMID: 33179443 DOI: 10.1111/jcmm.16085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhao X, Ren Y, Cui N, Wang X, Cui Y. Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis. Medicine (Baltimore) 2018;97:e12632. [PMID: 30278585 DOI: 10.1097/MD.0000000000012632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Liu W, Yin C, Liu Y. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis. Cancer Biother Radiopharm 2020. [PMID: 32673066 DOI: 10.1089/cbr.2019.3472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Bizhani F, Hashemi M, Danesh H, Nouralizadeh A, Narouie B, Bahari G, Ghavami S. Association between single nucleotide polymorphisms in the PI3K/AKT/mTOR pathway and bladder cancer risk in a sample of Iranian population. EXCLI J 2018;17:3-13. [PMID: 29383014 DOI: 10.17179/excli2017-329] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Wu C, Wang M, Huang Q, Guo Y, Gong H, Hu C, Zhou L. Aberrant expression profiles and bioinformatic analysis of CAF-derived exosomal miRNAs from three moderately differentiated supraglottic LSCC patients. J Clin Lab Anal 2021;:e24108. [PMID: 34788477 DOI: 10.1002/jcla.24108] [Reference Citation Analysis]
17 Yu Y, Cai O, Wu P, Tan S. MiR‐490‐5p inhibits the stemness of hepatocellular carcinoma cells by targeting ECT2. J Cell Biochem 2019;120:967-76. [DOI: 10.1002/jcb.27459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Bai J, Yeh S, Qiu X, Hu L, Zeng J, Cai Y, Zuo L, Li G, Yang G, Chang C. TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals. Oncogene 2018;37:5901-12. [DOI: 10.1038/s41388-018-0269-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
19 Wu L, Zhang M, Qi L, Zu X, Li Y, Liu L, Chen M, Li Y, He W, Hu X, Mo M, Ou Z, Wang L. ERα-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion. Cell Death Dis 2019;10:635. [PMID: 31455760 DOI: 10.1038/s41419-019-1827-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
20 Xu B, Xu T, Liu H, Min Q, Wang S, Song Q. MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells. Pharmacology 2017;100:269-82. [PMID: 28810242 DOI: 10.1159/000477667] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
21 Dong W, Wu P, Zhou D, Huang J, Qin M, Yang X, Wan M, Zong Y. Ultrasound-Mediated Gene Therapy of Hepatocellular Carcinoma Using Pre-microRNA Plasmid-Loaded Nanodroplets. Ultrasound in Medicine & Biology 2020;46:90-107. [DOI: 10.1016/j.ultrasmedbio.2019.09.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Liu J, Tian Z, Liu T, Wen D, Ma Z, Liu Y, Zhu J. CHSY1 is upregulated and acts as tumor promotor in gastric cancer through regulating cell proliferation, apoptosis, and migration. Cell Cycle 2021;20:1861-74. [PMID: 34412565 DOI: 10.1080/15384101.2021.1963553] [Reference Citation Analysis]
23 Ren HX, Zhang FC, Luo HS, Zhang G, Liang LX. Role of mast cell-miR-490-5p in irritable bowel syndrome. World J Gastroenterol 2017; 23(1): 93-102 [PMID: 28104984 DOI: 10.3748/wjg.v23.i1.93] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
24 Huang Y, Ma Z, Cui YH, Dong HS, Zhao JM, Dou CZ, Liu HR, Li J, Wu HG. Effects of Herb-Partitioned Moxibustion on the miRNA Expression Profiles in Colon from Rats with DSS-Induced Ulcerative Colitis. Evid Based Complement Alternat Med 2017;2017:1767301. [PMID: 28246536 DOI: 10.1155/2017/1767301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
25 Li H, Zhao X, Wen X, Zeng A, Mao G, Lin R, Hu S, Liao W, Zhang Z. Inhibition of miR-490-5p Promotes Human Adipose-Derived Stem Cells Chondrogenesis and Protects Chondrocytes via the PITPNM1/PI3K/AKT Axis. Front Cell Dev Biol 2020;8:573221. [PMID: 33240879 DOI: 10.3389/fcell.2020.573221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
26 Wang Z, Shang J, Li Z, Li H, Zhang C, He K, Li S, Ju W. PIK3CA Is Regulated by CUX1, Promotes Cell Growth and Metastasis in Bladder Cancer via Activating Epithelial-Mesenchymal Transition. Front Oncol 2020;10:536072. [PMID: 33344221 DOI: 10.3389/fonc.2020.536072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Abdeyrim A, Cheng X, Lian M, Tan Y. miR‑490‑5p regulates the proliferation, migration, invasion and epithelial‑mesenchymal transition of pharyngolaryngeal cancer cells by targeting mitogen‑activated protein kinase kinasekinase 9. Int J Mol Med 2019;44:240-52. [PMID: 31115491 DOI: 10.3892/ijmm.2019.4196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
28 Li FZ, Zang WQ. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells. World J Gastroenterol 2019; 25(42): 6299-6310 [PMID: 31754291 DOI: 10.3748/wjg.v25.i42.6299] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
29 Zeng JH, Lu W, Liang L, Chen G, Lan HH, Liang XY, Zhu X. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data. J Transl Med 2019;17:281. [PMID: 31443717 DOI: 10.1186/s12967-019-2032-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
30 He T, Ling F. CALCR knockdown inhibits the development and progression of non-small-cell lung cancer. Carcinogenesis 2021;42:1390-8. [PMID: 34417812 DOI: 10.1093/carcin/bgab076] [Reference Citation Analysis]